CITY OF CAPE TOWN
2293
VIEWS
VIEWS
Company News
UCT Designs AIDS Vaccine
Recent Company News
- Road closures during World Cup
- Athlone Cooling Towers to be Demolished
- 10 Things Travelers Need when Visiting Cape Town
- Final Draw Controlled Access and Exclusion Zone
- Preliminary testing starts on stadium lights
- City of Cape Town rated as top service provider
- Slow and steady saves the day – and the pay
- City events add to Cape Town Green Week momentum
- Housing challenge met through successful partnering
- New pilot project to reduce water loss
- Cape Town prepares for Diwali celebrations
The University of Cape Town (UCT) has designed a vaccine with the help of health Institutes from the U.S.A, this is a huge step in the medical field for South Africa. As a third world nation we amongst many other African nations are severely affected by this disease. The vaccines, are to be tested this month as the first third world designed AIDS vaccine.
In the article below Michelle Faul reports on the steps to be taken for the vaccine and South Africa's past concerning AIDS/HIV. Also the way forward in research and developments in terms a Vaccine for this world wide pandemic. Use the navigation link to view various articles on health and The City of Cape Town on CBN's website as well as business articles.
South Africa tests AIDS vaccine
By MICHELLE FAUL
South Africa is launching clinical trials of the first AIDS vaccines created by a developing country, a feat by scientists who forged ahead even when some of their political leaders shocked the world with unscientific pronouncements about the disease.
Trials to test the safety in humans of the vaccines begin this month on 36 healthy volunteers, Anthony Mbewu, president of South Africa's government-supported Medical Research Council, said in an interview Sunday. Mbewu's respected organization shepherded the project.
A trial of 12 volunteers in the United States began earlier this year.
Mbewu said the vaccine was designed at the University of Cape Town with technical help from the U.S. National Institutes of Health, which also manufactured the vaccine.
Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Disease and a leading AIDS researcher, was in South Africa for the launch.
During nearly 10 years of denial and neglect, South Africa developed a staggering AIDS crisis. Around 5.2 million South Africans were living with HIV last year — the highest number of any country in the world. Young women are hardest hit, with one-third of those aged 20 to 34 infected with the virus.
In 1999, the ministries of health and of science and technology founded the vaccine initiative and poured 250 million rand into it over nearly 10 years.
Some 250 scientists and technicians worked on the project, along the way gaining scores of doctorates and producing work for professional publications as well as a model for continued biotechnology development in South Africa.
The government decided it was important to develop a vaccine specifically for the HIV subtype C strain that is prevalent in southern Africa "and to ensure that once developed, it would be available at an affordable price," Mbewu said.
"We have the biggest problem" in the world, Mbewu said on the sidelines of an international AIDS conference in Cape Town.
"Every emerging country is trying, wants to develop their own capacity to design and develop vaccines — Brazil, Korea," Mbewu said.
But the South Africans are the first to reach the clinical trial stage, though years of testing will be needed.
At the AIDS conference later, South Africa's Vice President Kgalema Motlanthe emphasized the clinical trials are being held "under strict ethical rules." The first trial may have been started in the United States to allay any criticism that the U.S. was collaborating in an AIDS vaccine that would use Africans as guinea pigs.
The field of AIDS vaccine research is so filled with disappointments some activists are questioning the wisdom of continuing such expensive investments, saying the money might be better spent on prevention and education.
Mbewu said the crisis in South Africa more than justifies the expenditure.
"With 5.2 million already infected and with hundreds getting infected every day despite all the condom distribution and behavioral education programs, we know that a vaccine really is what we need," he said.
And he said there are many other benefits. The cadre of South African scientists now able to develop complex technological vaccines for HIV can use that same expertise to fight tuberculosis and avian flu.
"When the next influenza pandemic hits the world, every country will be scrambling to develop a vaccine ... so it is important that countries like South Africa have the technology and capacity to develop vaccines and the industry to manufacture them," Mbewu said.
South Africa was the site of the biggest setback to AIDS vaccine research, when the most promising vaccine ever, produced by Merck & Co. and tested in a study in South Africa in 2007, found that people who got the vaccine were more likely to contract HIV than those who did not.
In the 1990s, South Africa's then-President Thabo Mbeki denied the link between HIV and AIDS, and his health minister, Manto Tshabalala-Msimang, mistrusted conventional anti-AIDS drugs and made the country a laughing stock trying to promote beets and lemon as AIDS remedies.
At the conference opening, co-chairman Dr. Hoosen Jerry Coovadia reminded the thousands of scientists, researchers, doctors and activists of the importance the international scientific community had made to South Africa's progress in mounting an effective AIDS response in 2000, when the largest international AIDS meeting was held in the South African port city of Durban.
Some 5,000 scientists signed the Durban declaration that affirmed the human immunodeficiency virus was the cause of AIDS.
Coovadia, who is professor in HIV/AIDS research at the University of Natal-Durban, said today the international science community must ensure that governments keep their commitment to ensuring universal access to life-giving anti-retroviral drugs.
It was the Durban conference that opened the way for the rollout of ARV therapy in poor and middle-income countries where today more than 3 million people are receiving treatment, said Dr. Julio Montaner, president of the International AIDS Society.
He said those gains are threatened today by warnings that the global financial crisis must affect supplies of ARVs.
Montaner said it was extraordinary that the United States is the only member of the G-8 conference of rich developing countries that has paid up what it promised to fight AIDS.
"We must hold the G-8 leaders accountable for their failure to deliver on their promises," Montaner said.
"A retrenchment now would be catastrophic for the nearly 4 million people who are already on treatment in resource-limited countries" and some 7 million others waiting for treatment.
"AIDS is not in recession!" South African AIDS activist Vusikeya Dubula said to cheers from the conference. "
In the article below Michelle Faul reports on the steps to be taken for the vaccine and South Africa's past concerning AIDS/HIV. Also the way forward in research and developments in terms a Vaccine for this world wide pandemic. Use the navigation link to view various articles on health and The City of Cape Town on CBN's website as well as business articles.
South Africa tests AIDS vaccine
By MICHELLE FAUL
South Africa is launching clinical trials of the first AIDS vaccines created by a developing country, a feat by scientists who forged ahead even when some of their political leaders shocked the world with unscientific pronouncements about the disease.
Trials to test the safety in humans of the vaccines begin this month on 36 healthy volunteers, Anthony Mbewu, president of South Africa's government-supported Medical Research Council, said in an interview Sunday. Mbewu's respected organization shepherded the project.
A trial of 12 volunteers in the United States began earlier this year.
Mbewu said the vaccine was designed at the University of Cape Town with technical help from the U.S. National Institutes of Health, which also manufactured the vaccine.
Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Disease and a leading AIDS researcher, was in South Africa for the launch.
During nearly 10 years of denial and neglect, South Africa developed a staggering AIDS crisis. Around 5.2 million South Africans were living with HIV last year — the highest number of any country in the world. Young women are hardest hit, with one-third of those aged 20 to 34 infected with the virus.
In 1999, the ministries of health and of science and technology founded the vaccine initiative and poured 250 million rand into it over nearly 10 years.
Some 250 scientists and technicians worked on the project, along the way gaining scores of doctorates and producing work for professional publications as well as a model for continued biotechnology development in South Africa.
The government decided it was important to develop a vaccine specifically for the HIV subtype C strain that is prevalent in southern Africa "and to ensure that once developed, it would be available at an affordable price," Mbewu said.
"We have the biggest problem" in the world, Mbewu said on the sidelines of an international AIDS conference in Cape Town.
"Every emerging country is trying, wants to develop their own capacity to design and develop vaccines — Brazil, Korea," Mbewu said.
But the South Africans are the first to reach the clinical trial stage, though years of testing will be needed.
At the AIDS conference later, South Africa's Vice President Kgalema Motlanthe emphasized the clinical trials are being held "under strict ethical rules." The first trial may have been started in the United States to allay any criticism that the U.S. was collaborating in an AIDS vaccine that would use Africans as guinea pigs.
The field of AIDS vaccine research is so filled with disappointments some activists are questioning the wisdom of continuing such expensive investments, saying the money might be better spent on prevention and education.
Mbewu said the crisis in South Africa more than justifies the expenditure.
"With 5.2 million already infected and with hundreds getting infected every day despite all the condom distribution and behavioral education programs, we know that a vaccine really is what we need," he said.
And he said there are many other benefits. The cadre of South African scientists now able to develop complex technological vaccines for HIV can use that same expertise to fight tuberculosis and avian flu.
"When the next influenza pandemic hits the world, every country will be scrambling to develop a vaccine ... so it is important that countries like South Africa have the technology and capacity to develop vaccines and the industry to manufacture them," Mbewu said.
South Africa was the site of the biggest setback to AIDS vaccine research, when the most promising vaccine ever, produced by Merck & Co. and tested in a study in South Africa in 2007, found that people who got the vaccine were more likely to contract HIV than those who did not.
In the 1990s, South Africa's then-President Thabo Mbeki denied the link between HIV and AIDS, and his health minister, Manto Tshabalala-Msimang, mistrusted conventional anti-AIDS drugs and made the country a laughing stock trying to promote beets and lemon as AIDS remedies.
At the conference opening, co-chairman Dr. Hoosen Jerry Coovadia reminded the thousands of scientists, researchers, doctors and activists of the importance the international scientific community had made to South Africa's progress in mounting an effective AIDS response in 2000, when the largest international AIDS meeting was held in the South African port city of Durban.
Some 5,000 scientists signed the Durban declaration that affirmed the human immunodeficiency virus was the cause of AIDS.
Coovadia, who is professor in HIV/AIDS research at the University of Natal-Durban, said today the international science community must ensure that governments keep their commitment to ensuring universal access to life-giving anti-retroviral drugs.
It was the Durban conference that opened the way for the rollout of ARV therapy in poor and middle-income countries where today more than 3 million people are receiving treatment, said Dr. Julio Montaner, president of the International AIDS Society.
He said those gains are threatened today by warnings that the global financial crisis must affect supplies of ARVs.
Montaner said it was extraordinary that the United States is the only member of the G-8 conference of rich developing countries that has paid up what it promised to fight AIDS.
"We must hold the G-8 leaders accountable for their failure to deliver on their promises," Montaner said.
"A retrenchment now would be catastrophic for the nearly 4 million people who are already on treatment in resource-limited countries" and some 7 million others waiting for treatment.
"AIDS is not in recession!" South African AIDS activist Vusikeya Dubula said to cheers from the conference. "
Date Posted: 2009-07-20
Posted By: CITY OF CAPE TOWN
Listed under these Business Listing Categories: Business services & consultants,
More Company News
- Cape Town prepares for Diwali celebrations
- City awarded for promoting the right to access to information
- New unit in dogged pursuit of illegal drugs
- Deadline looms for public comments on Spatial Development Framework
- City scoops green prize
- Welcome to Cape Town !
- Cape Town opens its doors with accommodation policy
- Name our new stadium
- Cape Town stadium workers catch soccer fever
- Green Point Stadium Visitor Centre closes
- Learner Drivers Fail to Keep Test Appointments
- City’s new Climate Change Think-Tank to lead local interventions
- City signs Cape Town Responsible Tourism Charter
- 2010 Green Goal programme firmly on track
- Cruise ships take advantage of Cup
- Cape Town Tourists Have New Option
- Cape Town, South Africa, City of Beauty and History
- Gold Reef CEO Pushing for Another CT Metropole Casino
- Holiday in the City of Cape Town
- Review of Cape Town Fashion Week
- Cape Town Attracting the Celebrities
- SA in Homeless Soccer World Cup
- The H1N1 Virus - Questions and Answers
- Cape Town Leads the Way in Education
- City of Cape Town Reviews Annual Developement Plan
- Cape Town City Closely Monitors Adverse Weather
- City of Cape Town CCV Camera's Increased
- City of Cape Town Agrees to Security Presence
- Cape Town on Track with Broadband Project
- Cape Town Sets its Sights on an Entrepreneurship Ecosystem
- City of Cape Town an Independant Republic
- Must-Do's While in Cape Town
- Cape Town Hosts Final Draw for 2010
- 5 Attractions for Cape Town
- Cape Town - City of Beauty and History
- Accommodation in Cape Town: What to Look for
- Cape Town, a Tourist Mecca
- Table Mountain Shortlisted for New7Wonders
- Kgalema Motlanthe Speaks at AIDS Conference
- UCT Designs AIDS Vaccine
- Service Delivery in The Cape Improving
- Cape Gets Thumbs Up From A-G
- Cape Town Best In Africa
- CT Traffic Department Introduces the Ghost Squad
- 2010 Stadium Workers Strike
- Save Electricity
- Cape rapid transit system Gets The Go Ahead
- Cape Town CBD's New Office and Retail Space
- Cape Town Entrepreneurs Expand International Trade
- The City of Tape Town Promotes Economic Growth
- Cape Town - The Most Beautiful Holiday Destination
- Cape Town is 3rd Best Tourist city
- A Preface Of Cape Town
- Cape Town - Wealth of Attractions
- Cape Town A Growing Tourist Destination
- Holiday in Cape Town - The Beauty Of Africa
- SERVICE DELIVERY CONTINUES DURING SAMWU STRIKE
- City to Sign Lease and Sale Agreements to Private Sector of Owned Industrial Land in Atlantis
- BUMPER FESTIVE SEASON FOR CITY IN SNAP SURVEY
- DEPUTY MAYOR TO WELCOME COMPETITORS IN THE HOT ROD WORLD CUP
- COUNCIL APPROVES R300 MILLION FOR A FIBRE OPTIC NETWORK
- City Terminates Tourist Attraction Greenmarket Square Lease
- CITY TO HOST THIRD PROPERTY DEVELOPERS’ FORUM
- Sprinboks Set to Paint the City Green and Gold
- Cape Town Hotels World-Beater Status
- CAPE TOWN AS CRUISE LINER BASE
- GUGULETHU YOUTH SPORTS PROJECT FROM MONACO
- MARATHON ON CAPE TOWN’S ROADS
- CAPE TOWN PROGRESS ON PROPERTY VALUATIONS
- AN EVENTS COMMISSION FOR CAPE TOWN– A FIRST IN SA
- R1.34 MILLION FOR CAPE TOWN TABLE MOUNTAIN SAFETY
- Hundreds of Cape Flats Entrepreneurs Benefit From Business Vouchers
- Cape Town Ratepayers Urged to Look at Total Account
- Cape Town City Review
- Cape Town has Positive Response to Renaming Process
- Cape Town Renaming Process in Second Phase
- Cape Town Best City in Middle East and Africa Region
- Most Capetonians Support 2010 Stadium
- 2010 Stadium Redevelopment on Track
- Cape Town Street renaming Begins
- 2010 Triggers Massive Infrastructure Growth
- CAPE TOWN IS SA’S CALL CENTRE CAPITAL
- Cape Town Tourism Train Route
- Cape Town Cleanest City in SA
- 2010 Green Point Stadium Tender awarded
- Cape Town Tourism's visitor safety plan
- Cape Town property values and rates
- CITY OF CAPE TOWN TO PURSUE MUNICIPAL BONDS
![]() |
![]() |
|
![]() |
||
![]() |
![]() |
|
![]() |
![]() |
|
![]() Accommodation
![]() Foreign Exchange
![]() Directory
![]() Fax 2 Email
![]() Finance
![]() Furniture
![]() Online Casino
![]() Restaurant
![]() Shop Online
![]() Study IT Online
![]() Web Design
![]() Weddings
![]() Work from Home
|
||
![]() |
![]() |
|
![]() |
![]() |
|
Company News
|
||
![]() |
![]() |